Company location
Tokyo, Japan
TAKEDA PHARMACEUTICAL CO LTD has filed 676 SEC EDGAR filings since 05 Mar 2007

SEC filing history

Showing 26-50 of 662 matching filings.

Per page
25
Current page
2
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 Jul 2026
Reporting date
24 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 Jul 2026
Reporting date
24 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
06 Jul 2026
Reporting date
24 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
29 Jun 2026
Reporting date
29 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
26 Jun 2026
Reporting date
26 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
24 Jun 2026
Reporting date
24 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
24 Jun 2026
Reporting date
24 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
24 Jun 2026
Reporting date
24 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
IRANNOTICE File 001-38757

IRANNOTICE

Filing date
17 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .